Regencell Bioscience

US · RGC #2393 by market cap Listed 2021

7.11 -0.24 -3.27%

Live - 5344 symbols - heartbeat 141s ago · 2026-10-08 05:07

Pre-market 7.20 +1.27%

After-hours 7.11 0.00%

Overnight 6.89 -3.09%

Market cap: 3.53B
P/E (TTM): -296.25
P/B: 263.33
EPS: -0.02
Div yield: 0.00%
52W pos: 4%

Reader sentiment Are you bullish or bearish on RGC?

Anonymous reader poll. Unscientific, not investment advice.

About Regencell Bioscience

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Founded: 2014
CEO: Mr. Yat-Gai Au
Employees: 10
Headquarters: Hong Kong，China, HK, China
Fiscal year end: 06-30
Website: regencellbioscience.com

Company profile

Exchange: US
Symbol: RGC
Market-cap rank: #2393
Listing date: 2021-07-16
Market cap: 3.53B
Float cap: 400.95M
Shares out: 495.88M
Float shares: 56.39M

Sectors & themes

Drug Manufacturers - Specialty & Generic Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-10-08 05:07:29 · For reference only, not investment advice and not tailored to your situation.